Teladoc Health Inc
NYSE:TDOC
Teladoc Health Inc
Cash & Cash Equivalents
Teladoc Health Inc
Cash & Cash Equivalents Peer Comparison
Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Teladoc Health Inc
NYSE:TDOC
|
Cash & Cash Equivalents
$1.1B
|
CAGR 3-Years
15%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
Veeva Systems Inc
NYSE:VEEV
|
Cash & Cash Equivalents
$703.5m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
5%
|
CAGR 10-Years
10%
|
|
Inspire Medical Systems Inc
NYSE:INSP
|
Cash & Cash Equivalents
$175.4m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
Evolent Health Inc
NYSE:EVH
|
Cash & Cash Equivalents
$165.1m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
Doximity Inc
NYSE:DOCS
|
Cash & Cash Equivalents
$158m
|
CAGR 3-Years
48%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Goodrx Holdings Inc
NASDAQ:GDRX
|
Cash & Cash Equivalents
$672.3m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
81%
|
CAGR 10-Years
N/A
|
See Also
What is Teladoc Health Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
1.1B
USD
Based on the financial report for Mar 31, 2024, Teladoc Health Inc's Cash & Cash Equivalents amounts to 1.1B USD.
What is Teladoc Health Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
20%
Over the last year, the Cash & Cash Equivalents growth was 24%. The average annual Cash & Cash Equivalents growth rates for Teladoc Health Inc have been 15% over the past three years , 20% over the past five years .